本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BioLine Rx

2.48
-0.0400-1.59%
成交量:4,346
成交額:1.09萬
市值:1,202.55萬
市盈率:-1.57
高:2.54
開:2.52
低:2.48
收:2.52
52周最高:4.56
52周最低:2.15
股本:484.90萬
流通股本:458.73萬
量比:0.29
換手率:0.09%
股息:- -
股息率:- -
每股收益(TTM):-1.5822
每股收益(LYR):-0.2856
淨資產收益率:-55.27%
總資產收益率:-19.82%
市淨率:0.87
市盈率(LYR):-8.68

資料載入中...

2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/25

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/30

[修訂]年度報告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/07/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/28

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/05

[修訂]年度報告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/05/28

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/28

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]